Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03590054
Title Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rahul Aggarwal
Indications

Advanced Solid Tumor

Merkel cell carcinoma

malignant mesothelioma

transitional cell carcinoma

lung small cell carcinoma

gastroesophageal junction adenocarcinoma

head and neck squamous cell carcinoma

gastric adenocarcinoma

squamous cell carcinoma

melanoma

thymic carcinoma

lung non-small cell carcinoma

Therapies

Abexinostat + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.